MedPath

Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver

Not Applicable
Recruiting
Conditions
Fatty Liver
Registration Number
NCT05623930
Lead Sponsor
Cairo University
Brief Summary

fatty liver disease is characterized by low antioxidants, disturbed lipid metabolism, cardioautonomic functions, and elevated blood measures (glucose, inflammatory markers, liver enzymes)

Detailed Description

In fatty liver patients,applied cupping (with scarification) will be compared, regarding its effect on antioxidant, lipid metabolism, cardioautonomic functions, and blood measures (glucose, inflammatory markers, liver enzymes), to application of laser on acupoints

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • fatty liver obese patients
Exclusion Criteria

thoracic diseases heart diseases kidney diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
high density lipoprotein12 weeks

it is a component of lipid profile

Secondary Outcome Measures
NameTimeMethod
cholesterol12 weeks

it is a component of lipid profile

blood glucose12 weeks

fasting level of blood glucose will be measured

diastolic blood pressure12 weeks

it will be measured by sphygmomanometer

systolic blood pressure12 weeks

it will be measured by sphygmomanometer

low density lipoprotein12 weeks

it is a component of lipid profile

triglycerides12 weeks

it is a component of lipid profile

C reactive protein12 weeks

high sensitivity levels C reactive protein will be measured

aspartate transaminase12 weeks

it is a hepatic enzyme that reports the functions of liver

alanine transaminase12 weeks

it is a hepatic enzyme that reports the functions of liver

pulse rate12 weeks

it will be measured manually

Malondialdehyde12 weeks

it ts oxidative stress marker

Trial Locations

Locations (1)

Cairo Unoversity

🇪🇬

Giza, Egypt

Cairo Unoversity
🇪🇬Giza, Egypt
Ali Ismail, lecturer
Contact
01005154209
allooka2012@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.